Christobel Selecky, Director at ImmunityBio, Inc. (IBRX), sold 100,000 shares at $5.00 ($625K) on 2026-01-16, disclosed to the SEC on 2026-01-21.
Open-market sale of $625k IBRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 50,000 | $250K | 40.0% |
| 2 | $7.51 | 25,000 | $188K | 30.0% |
| 3 | $7.51 | 25,000 | $188K | 30.0% |
| Total | $6.25 avg | 100,000 | $625K | 100% |
| Filing → |
| IBRX | SELL | 2026-02-24 | $250K | — | Filing → |